Neurological Disorder Diagnostics Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation

Neurological Disorder Diagnostics Market Analysis | CMI


Read here the latest updates on the Neurological Disorder Diagnostics Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:1


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Neurological Disorder Diagnostics Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Neurological Disorder Diagnostics Market, by
    Technology (Imaging, and In Vitro Diagnostics),
    by Disease Indication (Genetic Neurological
    Disorders, Immunological Neurological Disorders,
    Paraneoplastic Syndrome, Paraproteinemic
    Neuropathies, and Others), by End User (Hospitals
    Clinics, Diagnostic Centers, and Ambulatory
    Care Centers), and by Region (North America,
    Latin America, Europe, Asia Pacific, Middle East,
    and Africa) - Size, Share, Outlook, and
    Opportunity Analysis, 2019 - 2027
  • The global neurological disorder diagnostics
    market size is expected to be valued at US
    12,162.6 million in 2019 and is expected to
    exhibit a CAGR of 7.6 over the forecast period

Figure 1. Global Neurological Disorder
Diagnostics Market Value (US Mn), by Region, 2019
Market Drivers
  • Increasing number of approvals and launches of
    novel diagnostic tools
  • In the recent past, several key players in the
    market have received approval for launching novel
    diagnostic tools. Moreover, approval and launch
    of such novel tools in the market is expected to
    create lucrative environment for the global
    Neurological Disorder Diagnostics Market growth
    over the forecast period. For instance, in April
    2018, Canon Medical Systems received 510 (k)
    clearance from the U.S. Food and Drug
    Administration for its new Aquilion Precision
    (CT) scanner. Aquilion Precision is an ultra-high
    resolution CT system (UHR CT).
  • Moreover, in March 2018, Koninklijke Philips N.V.
    launched its new 3-tesla MRI scanner, Elition
    3.0T. This new MRI scanner reduces scanning time
    by 50, which is expected to enhance patient
    experience. Furthermore, in January 2019, Canon
    Medical Systems Corporation launched Aquilion
    Start CT system with 16 and 32 slice
    configurations suitable for institutions aspiring
    to make diagnostic CT imaging more accessible and

  • Increasing strategic collaborations for
    development of new diagnostic tools is expected
    to propel the market growth
  • Strategic collaborations among key players are
    expected to fuel growth of the global
    neurological disorder diagnosis market over the
    forecast period. For instance, in March 2018,
    Canon Medical Systems, Kumamoto University, and
    University of Bordeaux entered into a
    collaborative research for the development of
    deep learning technology in magnetic resonance
  • Moreover, in 2017, Singapore-based National
    Neuroscience Institute and Nanyang Technological
    University (NTU Singapore) collaborated to
    develop novel and innovative technologies for
    better diagnosis and treatment of patients with
    neurological conditions such as Parkinsons
    disease, and brain injuries.
  • Furthermore, in January 2017, Siemens
    Healthineers and Biogen signed an agreement to
    develop new MRI tools for multiple sclerosis.

Market Restraints
  • However, high cost of diagnostic tools such as
    MRI machines and CT scan is a major factor, which
    is expected to hinder growth of global
    neurological disorder diagnostics market in
    emerging economies such as India, and China.
    According to American Health Imaging, price of a
    magnetic resonance imaging (MRI) devices starts
    from US 150,000, and a high end device costs
    more than US 1 million. Such high cost devices
    are only adopted by big hospitals and diagnostic

Figure 2. Global Neurological Disorder
Diagnostics Market Share (), by Disease
Key Players
  • Major players operating in the global
    neurological disorder diagnostics market include
    Siemens Healthineers, Koninklijke Philips N.V.,
    General Electric Company, Esaote SpA, NeuroLogica
    Corporation, Masimo Corporation, York Instruments
    Ltd., Neusoft Medical Systems, and Canon Medical
    Systems Corporation

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//